エピソード

  • New Considerations in Managing Family Planning in Multiple Sclerosis

    New Considerations in Managing Family Planning in Multiple Sclerosis
    2025/05/08

    What are the key challenges that women with multiple sclerosis (MS) face during their pregnancy journey?

    Credit available for this activity expires: 4/30/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002489?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    55 分
  • Advancing Precision Oncology: Recent Progress and Future Outlook

    Advancing Precision Oncology: Recent Progress and Future Outlook
    2025/05/01

    Did you know that there are several approved tumor agnostic therapies? Join our experts for an in-depth discussion.

    Credit available for this activity expires: 04/30/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-precision-oncology-recent-progress-and-future-2025a1000a6b?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    39 分
  • Advanced HER2-Positive Gastric/GEJ Cancers: Expert Insights on Current and Future Strategies

    Advanced HER2-Positive Gastric/GEJ Cancers: Expert Insights on Current and Future Strategies
    2025/04/30

    Do you know the latest strategies to optimize care for HER2-positive gastric and gastroesophageal junction (GEJ) cancers?

    Credit available for this activity expires: 4/30/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002494?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    38 分
  • Decoding PD-L1 Scoring: Guiding Immunotherapy for Gastroesophageal Cancers

    Decoding PD-L1 Scoring: Guiding Immunotherapy for Gastroesophageal Cancers
    2025/04/29

    Did you know that tumor area positivity (TAP) scoring can be completed up to 6 times faster than combined positive score (CPS)?

    Credit available for this activity expires: 4/23/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002476?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    38 分
  • Patient-Centered Paroxysmal Nocturnal Hemoglobinuria Treatment & the Role of Terminal Complement Inhibitors

    Patient-Centered Paroxysmal Nocturnal Hemoglobinuria Treatment & the Role of Terminal Complement Inhibitors
    2025/03/31

    Do you know how important treatment convenience and quality of life are to patients when selecting paroxysmal nocturnal hemoglobinuria (PHN) therapy?

    Credit available for this activity expires: 3/31/2026
    Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002332?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    37 分
  • Are We Undertreating Depression in People Living With Epilepsy?

    Are We Undertreating Depression in People Living With Epilepsy?
    2025/03/31

    Eight answers to help you do better for these patients.

    Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002029?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    16 分
  • Pearls on Retina Biomarkers for Clinical Practice

    Pearls on Retina Biomarkers for Clinical Practice
    2025/03/28

    What's more important, subretinal or intraretinal fluid? What markers indicate inflammation and fibrosis?

    Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002361?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    18 分
  • Sharing Expert Minds in Lung Cancer and Lung Neuroendocrine Tumors Delivering Optimal Patient Care

    Sharing Expert Minds in Lung Cancer and Lung Neuroendocrine Tumors Delivering Optimal Patient Care
    2025/03/20

    Did you know that lung neuroendocrine tumors (NETs) are often misdiagnosed as lung cancer due to overlapping imaging and histological features?

    Credit available for this activity expires: 3/18/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002284?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    36 分